|
Table 17.2.1: Summary of desktop
research on international HIA methodology guidelines 17-2
Table 17.2.2: Summary of desktop research
on HIA methodologies adopted in other airport related studies 17-3
Table 17.2.3: Summary of desktop research
on HIA methodologies adopted in other EIA studies and feasibility studies 17-5
Table 17.2.4: Summary of approaches in determination of health
risk identified from the literature review_ 17-5
Table 17.2.5: The limitation of different risk
assessment approaches 17-6
Table 17.2.6: Ozone concentrations
for with and without airport scenarios under northern wind direction_ 17-7
Table 17.2.7: Ozone concentrations for with
and without airport scenarios under southern wind direction_ 17-7
Table 17.2.8: Ozone concentrations for with
and without airport scenarios under western wind direction_ 17-8
Table 17.2.9: TAP considered in
various international guidelines 17-8
Table 17.2.10: TAP considered in various
airport-related health impact assessments / monitoring_ 17-9
Table 17.2.11: Summary of
short-listed TAP_ 17-13
Table 17.2.12: Modelling scenarios
to be assessed_ 17-14
Table 17.2.13: Human receptor
locations considered in local and international HIA studies 17-15
Table 17.2.14: Representative
existing and planned human receptors 17-16
Table 17.2.15: Potential exposure
pathways for different population_ 17-20
Table 17.2.16: Methodology for
determination of TAP speciation profile for airport activities 17-23
Table 17.2.17: Methodology for
determination of TAP speciation profile for proximity infrastructure emission
in Lantau area_ 17-25
Table 17.2.18: Methodology for
determination of TAP speciation profile for proximity infrastructure emission
in Tuen Mun area_ 17-25
Table 17.2.19: Modelling Methodology
for different type of receivers 17-27
Table 17.2.20: Summary of emission
targets in PRDEZ_ 17-28
Table 17.2.21: Summary of emission
targets in HKSAR_ 17-28
Table 17.2.22: Consequences of exposure to the key TAP for
airport related sources 17-29
Table 17.2.23: Basis of risk values in
different guidelines 17-36
Table 17.2.24: Summary of key
literature to establish the carcinogenic classification and unit risk for
cancer 17-37
Table17.2.25: Cancer risk guidelines 17-38
Table 17.2.26: Toxicity criteria of
the acute, carcinogenic and chronic non-carcinogenic risks of the identified
TAP_ 17-38
Table 17.2.27: Percentage of excess
risk (95% of confidence interval) of short-term mortalities and
morbidities attributable to a 10 µg/m3 increase in air pollutant
concentrations (for all ages) 17-40
Table 17.2.28: Percentage of excess
risk (95% of confidence interval) of long-term mortalities attributable
to air pollutants 17-40
Table 17.2.29: Summary of parameters
for hospital illnesses health outcome_ 17-42
Table 17.2.30: Summary of parameters for
premature death mortality health outcome_ |